BETASERC Trademark

Trademark Overview

On Friday, May 28, 2021, a trademark application was filed for BETASERC with the United States Patent and Trademark Office. The USPTO has given the BETASERC trademark a serial number of 90741935. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Wednesday, September 25, 2024. This trademark is owned by Otolanum AG. The BETASERC trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment or prevention of vestibular disorders, circulatory disorders, vascular disorders and neurological disorders
betaserc

General Information

Serial Number90741935
Word MarkBETASERC
Filing DateFriday, May 28, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateWednesday, September 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 22, 2022

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment or prevention of vestibular disorders, circulatory disorders, vascular disorders and neurological disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 23, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOtolanum AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBasel 4052
CH
Party NameOtolanum AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZug 6300
CH

Trademark Events

Event DateEvent Description
Tuesday, June 1, 2021NEW APPLICATION ENTERED
Thursday, February 10, 2022ASSIGNED TO EXAMINER
Thursday, February 10, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 22, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, October 21, 2022SOU EXTENSION 1 FILED
Tuesday, May 17, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, October 21, 2022SOU TEAS EXTENSION RECEIVED
Friday, October 21, 2022SOU EXTENSION 1 GRANTED
Tuesday, October 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 27, 2023SOU EXTENSION 2 FILED
Thursday, April 27, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 27, 2023SOU EXTENSION 2 GRANTED
Saturday, September 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 30, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 30, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 30, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, April 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 14, 2023SOU TEAS EXTENSION RECEIVED
Thursday, September 14, 2023SOU EXTENSION 3 FILED
Thursday, September 14, 2023SOU EXTENSION 3 GRANTED
Tuesday, April 30, 2024SOU EXTENSION 4 FILED
Tuesday, April 30, 2024SOU EXTENSION 4 GRANTED
Tuesday, April 30, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, May 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 25, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 25, 2024SOU EXTENSION 5 GRANTED
Wednesday, September 25, 2024SOU EXTENSION 5 FILED

Related Keywords

betaserc disorders circulatory neurological vascular vestibular preparations treatment prevention pharmaceutical